Counterfeit Drugs & Theft in the
U.S. Supply Chain

As your partner in DSCSA compliance, InfiniTrak strives to make sure our customers have the knowledge and tools needed to not only be compliant with the regulations but also provide awareness of important news that may affect the pharmaceutical drug supply chain.  Here are 3 recent notices of recent news:

December 21, 2023, the FDA released an article warning the pharmaceutical industry about counterfeit Ozempic (semaglutide) being sold in the U.S. The FDA encourages pharmacists, doctors, and patients to check the product’s lot & serial number before distributing or using. The counterfeit is lot NAR0074 and serial number 430834149057. For more details on what to look for, check out the FDA’s article.

Although they have seized a large portion of counterfeit Ozempic, some of the products are still available. Testing of the seized product is still ongoing. They have identified that the needles may not be sterile which could lead to infection.

View the latest article here from the FDA.

January 16, 2024 someone robbed a CVS Pharmacy in St. Petersburg Florida. The thief brandished a weapon and threatened the staff who instantly handed over the drugs that were demanded. Learn more.

December 2023, NABP & HDA notified the industry about a stolen cargo truck. The truck had pallets of medications like Omeprazole, Albuterol, Meloxicam and more. The incident occurred at a rest area in Ohio. Although the semi was recovered, the trailer of cargo was not. Learn more.

We will continue to share information and articles like this as we are made aware of them. Together, we can improve supply chain security and provide peace of mind regarding patient safety.